CSF3 and neutropenia: Therefore, with this study, aiming to explore the risk factors for neutropenia after CRT for EC, screening for more effective and cost-efficient prophylactic application of G-CSF in high-risk populations, more precise and rational prevention of neutropenia during CRT in patients with EC, thereby reducing patient hospitalization rates, lowering patient treatment costs, and increasing patient survival.